Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device
Key claim: The FDA is placing implanted tibial electrical stimulators used for urinary continence into the moderate-risk (class II) category with specific safety controls, which should make it easier for similar devices to reach patients.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the implanted tibial electrical urinary continence device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the implanted tibial electrical urinary continence device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Classifying implanted tibial electrical stimulators for urinary continence as Class II with special controls sets a 510(k) pathway rather than requiring premarket approval, which typically shortens the time and cost for competing devices to reach patients with urge incontinence or overactive bladder. It continues a pattern of FDA down-classifying niche urology neurostimulators once enough data supports moderate-risk special controls.